STAGE II LUNG CANCER AJCC V8

This study tests whether a cancer drug called atezolizumab can be given safely at home to people with non-small cell lung cancer. Instead of going to a clinic, patients receive the injection under the skin from a nurse while using telemedicine. The goal is to see if this home-bas…

This study is for people with stage II or III non-small cell lung cancer who are not healthy enough for standard treatments. It tests a shorter, stronger radiation course followed by the immunotherapy drug atezolizumab. The goal is to see if this combination is safe and helps con…

This study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with limited stage small cell lung cancer live longer. About 544 participants will receive either chemoradiation alone or chemoradiation plus atezolizumab. The goal is to s…

This study tests whether adding the immunotherapy drug atezolizumab to standard radiation therapy helps people with early-stage non-small cell lung cancer live longer. About 480 high-risk patients will receive either radiation alone or radiation plus atezolizumab. The goal is to …

This phase III trial tests whether adding the drug AZD6738 to the immunotherapy durvalumab can help prevent lung cancer from returning after chemotherapy and surgery. About 630 adults with stage II to IIIB non-small cell lung cancer will be randomly assigned to receive either the…

This early-phase trial is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with radiation therapy is safe and effective for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal is to see if this approach ca…

This study compares two treatments for lung tumors: microwave ablation (using heat to kill cancer cells) and surgical wedge resection (removing a small piece of lung). It includes people with early or advanced lung cancer, sarcoma, or colorectal cancer that has spread to the lung…

This early-phase study tests a drug called NBTXR3, which makes cancer cells more sensitive to radiation, combined with a second round of radiation for people whose non-small cell lung cancer has returned and cannot be removed by surgery. The main goals are to find the safest dose…

This study tests an online program designed to improve social well-being and emotional support for women being treated for lung cancer. About 70 women with stage I to IV non-small cell lung cancer will take part. The program uses mindfulness and emotional processing techniques to…

This study looks at over 1,300 cancer patients to find out who is more likely to develop nerve damage (tingling or numbness in hands and feet) from taxane chemotherapy. Researchers will track factors like age, gender, and pre-existing conditions to create a prediction tool. The g…

This study tests a decision aid designed for people with non-small cell lung cancer. The tool helps patients and doctors talk together about treatment options, risks, and what matters most to the patient. About 98 adults with lung cancer will use the tool to see if it improves th…

This study tests a telehealth self-management program for people who have finished treatment for early-stage lung or colorectal cancer. The program coaches survivors on follow-up care, communication with doctors, and managing their health. Researchers want to see if it improves c…